Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather L Bloom

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Cardiovascular Electrophysiology|October 16, 2010
Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial)Smita Negi, Irfan Shukrullah, Emir Veledar, et al.
American Heart Journal|April 25, 2007
Long-term survival after successful inhospital cardiac arrest resuscitationHeather L Bloom, Irfan Shukrullah, Jose R Cuellar, et al.
Clinical Chemistry|June 30, 2007
Oxidative stress markers are associated with persistent atrial fibrillationRobert B Neuman, Heather L Bloom, Irfan Shukrullah, et al.
Cardiology Research and Practice|June 5, 2018
Improved Patient Outcomes by Normalizing Sympathovagal Balance: Differentiating Syncope-Precise Subtype Differentiation Leads to Improved OutcomesNicholas L DePace, Julie A Bateman, Michael Yayac, et al.
Journal of Cardiac Failure|September 4, 2012
Angiotensin receptor type 1 single nucleotide polymorphism 1166A/C is associated with malignant arrhythmias and altered circulating miR-155 levels in patients with chronic heart failureRaul R Blanco, Harland Austin, Richard N Vest, et al.
Journal of the American Heart Association|August 2, 2015
Left Ventricular Dilatation Increases the Risk of Ventricular Arrhythmias in Patients With Reduced Systolic FunctionRyan G Aleong, Matthew J Mulvahill, Indrani Halder, et al.
Pacing and Clinical Electrophysiology : PACE|October 15, 2010
Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelopeHeather L Bloom, Luis Constantin, Daniel Dan, et al.
The American Journal of Cardiology|February 16, 2015
Effect of angiotensin-converting enzyme inhibitors and receptor blockers on appropriate implantable cardiac defibrillator shock in patients with severe systolic heart failure (from the GRADE Multicenter Study)Wael A AlJaroudi, Marwan M Refaat, Robert H Habib, et al.
Heart Rhythm|October 19, 2011
Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathyMarwan M Refaat, Steven A Lubitz, Seiko Makino, et al.
The Journal of Clinical Investigation|February 20, 2018
A common variant alters SCN5A-miR-24 interaction and associates with heart failure mortalityXiaoming Zhang, Jin-Young Yoon, Michael Morley, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Cardiovascular Electrophysiology|October 16, 2010
Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial)Smita Negi, Irfan Shukrullah, Emir Veledar, et al.
American Heart Journal|April 25, 2007
Long-term survival after successful inhospital cardiac arrest resuscitationHeather L Bloom, Irfan Shukrullah, Jose R Cuellar, et al.
Clinical Chemistry|June 30, 2007
Oxidative stress markers are associated with persistent atrial fibrillationRobert B Neuman, Heather L Bloom, Irfan Shukrullah, et al.
Cardiology Research and Practice|June 5, 2018
Improved Patient Outcomes by Normalizing Sympathovagal Balance: Differentiating Syncope-Precise Subtype Differentiation Leads to Improved OutcomesNicholas L DePace, Julie A Bateman, Michael Yayac, et al.
Journal of Cardiac Failure|September 4, 2012
Angiotensin receptor type 1 single nucleotide polymorphism 1166A/C is associated with malignant arrhythmias and altered circulating miR-155 levels in patients with chronic heart failureRaul R Blanco, Harland Austin, Richard N Vest, et al.
Journal of the American Heart Association|August 2, 2015
Left Ventricular Dilatation Increases the Risk of Ventricular Arrhythmias in Patients With Reduced Systolic FunctionRyan G Aleong, Matthew J Mulvahill, Indrani Halder, et al.
Pacing and Clinical Electrophysiology : PACE|October 15, 2010
Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelopeHeather L Bloom, Luis Constantin, Daniel Dan, et al.
The American Journal of Cardiology|February 16, 2015
Effect of angiotensin-converting enzyme inhibitors and receptor blockers on appropriate implantable cardiac defibrillator shock in patients with severe systolic heart failure (from the GRADE Multicenter Study)Wael A AlJaroudi, Marwan M Refaat, Robert H Habib, et al.
Heart Rhythm|October 19, 2011
Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathyMarwan M Refaat, Steven A Lubitz, Seiko Makino, et al.
The Journal of Clinical Investigation|February 20, 2018
A common variant alters SCN5A-miR-24 interaction and associates with heart failure mortalityXiaoming Zhang, Jin-Young Yoon, Michael Morley, et al.
Pageof 3